Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €40.45 EUR
Change Today +0.253 / 0.63%
Volume 0.0
ZOE On Other Exchanges
New York
As of 1:47 PM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

zoetis inc (ZOE) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/20/15 - €45.87
52 Week Low
05/7/14 - €21.50
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ZOETIS INC (ZOE)

zoetis inc (ZOE) Details

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines for livestock and companion animals worldwide. The company operates through four segments: the United States; Europe/Africa/Middle East; Canada/Latin America; and Asia/Pacific. It offers anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; vaccines that are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; and parasiticides that prevent or eliminate external and internal parasites, such as fleas, ticks, and worms. The company also provides medicated feed additives that offer medicines to livestock; veterinarian solutions for anesthesia and treating pain and serious illnesses, such as diabetes; and other pharmaceutical products, including pain and sedation, oncology, antiemetic, allergy and dermatology, and reproductive products. In addition, it offers other product categories, such as nutritionals and agribusiness, as well as products and services in complementary areas, including diagnostics, genetics, biodevices, and services. The company markets its products to veterinarians and livestock producers through its sales representatives, and technical and veterinary operations specialists. Zoetis Inc. was founded in 1952 and is headquartered in Florham Park, New Jersey.

10,000 Employees
Last Reported Date: 02/27/15
Founded in 1952

zoetis inc (ZOE) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $1.1M
Group President and Executive Vice President
Total Annual Compensation: $620.4K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $207.6K
Executive Vice President and President of U.S...
Total Annual Compensation: $451.4K
President of Research & Development and Execu...
Total Annual Compensation: $451.4K
Compensation as of Fiscal Year 2014.

zoetis inc (ZOE) Key Developments

Zoetis Inc. Appoints Paul M. Bisaro to Board of Directors, Effective May 1, 2015

Zoetis Inc. announced that its Board of Directors has appointed Paul M. Bisaro, Executive Chairman of Actavis plc, to the company’s Board of Directors. Mr. Bisaro’s term will begin immediately following the company’s 2015 Annual Meeting of Shareholders, which is scheduled for May 1, 2015. With the addition of Mr. Bisaro, the Zoetis Board will expand to 11 directors, and he will serve on the Compensation Committee. He previously served as President, CEO and Chairman of the Board of Actavis. Prior to joining Actavis, he was President and Chief Operating Officer of Barr Pharmaceuticals Inc. He also served as General Counsel at Barr and held various additional roles, including Senior Vice President of Strategic Business Development. Prior to joining Barr, Mr. Bisaro was associated with the law firm Winston & Strawn and a predecessor firm, Bishop, Cook, Purcell and Reynolds. He also served as a Senior Consultant with Arthur Andersen & Co.

Zoetis Inc. to Report Q1, 2015 Results on May 05, 2015

Zoetis Inc. announced that they will report Q1, 2015 results at 8:30 AM, US Eastern Standard Time on May 05, 2015

Zoetis Inc., Q1 2015 Earnings Call, May 05, 2015

Zoetis Inc., Q1 2015 Earnings Call, May 05, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ZOE:GR €40.45 EUR +0.253

ZOE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abaxis Inc $53.15 USD -1.93
CEVA Inc $18.66 USD +0.21
IDEXX Laboratories Inc $126.96 USD -3.56
Vetoquinol SA €34.98 EUR +0.10
Virbac SA €231.15 EUR -7.65
View Industry Companies

Industry Analysis


Industry Average

Valuation ZOE Industry Range
Price/Earnings 38.4x
Price/Sales 4.7x
Price/Book 17.1x
Price/Cash Flow 34.7x
TEV/Sales 3.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZOETIS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at